2008
DOI: 10.1016/j.anclin.2007.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Anesthesia for the Pregnant HIV Patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
5

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 45 publications
0
2
0
5
Order By: Relevance
“…There are concerns regarding cardiac problems (myocarditis, cardiomyopathy, accelerated atherosclerosis) with protease inhibitors, respiratory opportunistic infections (bacterial pneumonias and aspergillosis), central nervous system involvement (encephalopathy, demyelinating syndromes, infection induced space occupying lesions, dementia among others), diarrhea along with associated electrolyte abnormalities, nephropathy (may be associated with protease inhibitors like adefovir and indinavir), pancytopenia (aggravated by nucleoside reverse transcriptase inhibitors (NRTIs), thrombotic episodes in late stages, metabolic problems (lipodystrophy, insulin resistance aggravated by protease inhibitors), lactic acidosis and pancreatitis with NRTIs, allergic reactions and hepatic involvement with non-nucleoside reverse transcriptase inhibitors (NNRTIs), apart from autonomic and peripheral neuropathy which are quite common in HIV positive patients. 15 Oropharyngeal and esophageal pathology may make some patients susceptible to difficult intubation, regurgitation and aspiration. 16 Protease inhibitors and non-nucleoside reverse transcriptase inhibitors are the most commonly implicated group of anti-retrovirals in drug interactions.…”
Section: Discussionmentioning
confidence: 99%
“…There are concerns regarding cardiac problems (myocarditis, cardiomyopathy, accelerated atherosclerosis) with protease inhibitors, respiratory opportunistic infections (bacterial pneumonias and aspergillosis), central nervous system involvement (encephalopathy, demyelinating syndromes, infection induced space occupying lesions, dementia among others), diarrhea along with associated electrolyte abnormalities, nephropathy (may be associated with protease inhibitors like adefovir and indinavir), pancytopenia (aggravated by nucleoside reverse transcriptase inhibitors (NRTIs), thrombotic episodes in late stages, metabolic problems (lipodystrophy, insulin resistance aggravated by protease inhibitors), lactic acidosis and pancreatitis with NRTIs, allergic reactions and hepatic involvement with non-nucleoside reverse transcriptase inhibitors (NNRTIs), apart from autonomic and peripheral neuropathy which are quite common in HIV positive patients. 15 Oropharyngeal and esophageal pathology may make some patients susceptible to difficult intubation, regurgitation and aspiration. 16 Protease inhibitors and non-nucleoside reverse transcriptase inhibitors are the most commonly implicated group of anti-retrovirals in drug interactions.…”
Section: Discussionmentioning
confidence: 99%
“…В некоторых работах отмечены клинически значимые взаимодействия между антиретровирусными препаратами и препаратами для анестезии. Так, ингибиторы протеаз и ненук леозидные ингибиторы обратной транскриптазы взаимодейст вуют с бензодиазепинами (диазепам, мидазолам), потенцируя действие последних, что говорит о необходимости снижения дозы атарактиков при проведении анестезии [25]. У пациенток с ВИЧ инфекцией повышена чувствительность и к нейролеп тикам.…”
Section: о б з о р ыunclassified
“…Нуклеозидные инги биторы обратной транскриптазы способны подавляюще дейст вовать на мегакариоцитарный росток красного костного мозга и снижать выработку тромбоцитов [12]. Тромбоцитопения на фоне проводимой АРВТ диктует необходимость включения в комплекс предоперационной подготовки пульс терапию глю кокортикоидами [25,31].…”
Section: о б з о р ыunclassified
“…У деяких роботах відзначено клі нічно значущі взаємодії між антиретровірусними препара тами та препаратами для анестезії. Так, інгібітори протеаз і ненуклеозидні інгібітори зворотної транскриптази взаємо діють з бензодіазепінами (діазепам, мідазолам), потенцію ючи дію останніх, що свідчить про необхідність зниження дози атарактиків при проведенні анестезії [10]. У пацієнток з ВІЛінфекцією підвищена чутливість і до нейролептиків.…”
unclassified